China’s Biotech Rises, AI Drives Market Surge
Kilder
- Bioworld: Hengrui, BMS deal watershed moment for China biotech - BioWorld News
- Bioworld: Hengrui, BMS deal watershed moment for China biotech - BioWorld News
- Nature: Targeting toxic HTT1a could be the key to treating Huntington disease - Nature
- En: Fixing the Recipe: Lowering a Slice of Huntingtin - HDBuzz
- BioPharma Dive: Early data for heart drug affirm Lilly’s billion-dollar bet on Verve - BioPharma Dive
- STAT: Eli Lilly to buy three small vaccine developers - statnews.com
- Fierce Biotech: Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues - Fierce Biotech
- BioPharma Dive: Lilly dives into vaccine research with 3 biotech buyouts - BioPharma Dive
- BioSpace: Lilly lands vaccine trifecta with 3 new biotech buys valued at up to $3.8B - BioSpace
- BioSpace: Lilly announces three acquisitions to build infectious disease portfolio - BioSpace
- Fierce Biotech: Makary FDA reforms ‘continue to move forward’ despite turmoil - Fierce Biotech
- wikimedia: Photo by Timothydotuns / Wikimedia Commons / CC BY-SA 4.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.